RECRUITING

Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)

Talk to us

Conditions

Cigarette Smoking-Related Carcinoma

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates the amount of nicotine, cannabis, and toxicants linked to the use of nicotine e-cigarette and/or cannabis products in the blood and urine of young adult users as well as the cannabis and nicotine use behaviors of consumers.

Official Title

Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)

Quick Facts

Study Start:2025-04-03
Study Completion:2028-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07167225

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Young adult (18-25 years old).
  2. * Ability to read and write in English.
  3. * Participants must fall into one of the following groups (based on self-report):
  4. * Predominant e-cigarette consumer: defined as using nicotine-containing e-cigarettes daily for the past six months but not having used other nicotine containing products more than weekly or cannabis products for the past month.
  5. * Predominant cannabis consumer: defined as using cannabis at least 3x/week for the past six months in any form, including smoking, vaping, and oral use, with no more than weekly use of any nicotine or tobacco products.
  6. * E-cigarette-cannabis co-consumers: defined as daily use of nicotine e-cigarettes and use of cannabis at least 3x/week, including smoking, vaping, and oral use, for at least the past six months, with no use of other nicotine containing products more than weekly.
  7. * No self-reported diagnosis of kidney disease (current, or within the past year prior to the study visit).
  8. * Participants must understand the voluntary nature of this study and sign a written informed consent form before proceeding with study activities.
  1. * Individuals under the age of 18 or over the age of 25.
  2. * Currently pregnant or breastfeeding (female participants).
  3. * Unwilling or unable to follow protocol requirements

Contacts and Locations

Study Contact

ASK RPCI
CONTACT
1-800-767-9355
askroswell@roswellpark.org

Principal Investigator

Danielle Smith, PhD
PRINCIPAL_INVESTIGATOR
Roswell Park

Study Locations (Sites)

Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263
United States

Collaborators and Investigators

Sponsor: Roswell Park Cancer Institute

  • Danielle Smith, PhD, PRINCIPAL_INVESTIGATOR, Roswell Park

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-03
Study Completion Date2028-09-01

Study Record Updates

Study Start Date2025-04-03
Study Completion Date2028-09-01

Terms related to this study

Additional Relevant MeSH Terms

  • Cigarette Smoking-Related Carcinoma